Stooss A[au] - Search Results

Year	Number of Results
2000	1
2011	1
2017	2
2018	2
2019	2
2020	2
2021	1
2022	0

1

BRAF^V600E Overrides NOTCH Signaling in Thyroid Cancer.

Traversi F, Stooss A, Dettmer MS, Charles RP. Traversi F, et al. Among authors: stooss a. Thyroid. 2021 May;31(5):787-799. doi: 10.1089/thy.2019.0595. Epub 2020 Nov 12. Thyroid. 2021. PMID: 33012268

2

Frequency, Characteristics and Risk Factors of Aggressive Incidents in a Paediatric Rehabilitation Setting: A Prospective Survey.

Meier SBB, Uenver Y, Stooss A, Meyer-Heim A. Meier SBB, et al. Among authors: stooss a. Dev Neurorehabil. 2020 Jan;23(1):9-17. doi: 10.1080/17518423.2019.1604579. Epub 2019 May 6. Dev Neurorehabil. 2020. PMID: 31055992

3

The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model.

Häfliger P, Graff J, Rubin M, Stooss A, Dettmer MS, Altmann KH, Gertsch J, Charles RP. Häfliger P, et al. Among authors: stooss a. J Exp Clin Cancer Res. 2018 Sep 21;37(1):234. doi: 10.1186/s13046-018-0907-z. J Exp Clin Cancer Res. 2018. PMID: 30241549 Free PMC article.

4

Combined MEK and Pi3'-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivo.

ElMokh O, Ruffieux-Daidié D, Roelli MA, Stooss A, Phillips WA, Gertsch J, Dettmer MS, Charles RP. ElMokh O, et al. Among authors: stooss a. Oncotarget. 2017 Apr 11;8(15):24604-24620. doi: 10.18632/oncotarget.15599. Oncotarget. 2017. PMID: 28445948 Free PMC article.

5

Identifying Lysophosphatidic Acid Acyltransferase β (LPAAT-β) as the Target of a Nanomolar Angiogenesis Inhibitor from a Phenotypic Screen Using the Polypharmacology Browser PPB2.

Poirier M, Awale M, Roelli MA, Giuffredi GT, Ruddigkeit L, Evensen L, Stooss A, Calarco S, Lorens JB, Charles RP, Reymond JL. Poirier M, et al. Among authors: stooss a. ChemMedChem. 2019 Jan 22;14(2):224-236. doi: 10.1002/cmdc.201800554. Epub 2018 Dec 6. ChemMedChem. 2019. PMID: 30520265

6

PIK3CA^H1047R-induced paradoxical ERK activation results in resistance to BRAF^V600E specific inhibitors in BRAF^V600E PIK3CA^H1047R double mutant thyroid tumors.

Roelli MA, Ruffieux-Daidié D, Stooss A, ElMokh O, Phillips WA, Dettmer MS, Charles RP. Roelli MA, et al. Among authors: stooss a. Oncotarget. 2017 Oct 11;8(61):103207-103222. doi: 10.18632/oncotarget.21732. eCollection 2017 Nov 28. Oncotarget. 2017. PMID: 29262556 Free PMC article.

7

[Mature cystic teratoma--two decades of pain].

Paulus C, Stooss A, Lichtenhahn P, Schlüchter R, Schlosser S. Paulus C, et al. Among authors: stooss a. MMW Fortschr Med. 2011 Feb 17;153(7):40-1. MMW Fortschr Med. 2011. PMID: 21648141 German. No abstract available.

8

Bcl-2 transfected HaCaT keratinocytes resist apoptotic signals of ceramides, tumor necrosis factor alpha and 1 alpha, 25-dihydroxyvitamin D(3).

Müller-Wieprecht V, Riebeling C, Stooss A, Orfanos CE, Geilen CC. Müller-Wieprecht V, et al. Among authors: stooss a. Arch Dermatol Res. 2000 Sep;292(9):455-62. doi: 10.1007/s004030000158. Arch Dermatol Res. 2000. PMID: 11000289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results